肝硬化患者腹主动脉瘤腔内修复术后内张力
本文报告2例肝硬化患者EVAR术后3年随访中出现无内漏影像学证据的进行性瘤囊增大,均成功转为开放修复并证实内张力。提示肝硬化所致血浆改变可能影响EVAR远期疗效,在高危患者选择腔内或开放修复时应予考虑。
要点
- 肝硬化患者EVAR术后可出现无内漏证据的瘤囊进行性增大(内张力)。
- 肝硬化所致血浆改变可能影响EVAR远期疗效。
- 此类高危患者中,尽管手术风险高,转为开放修复仍可行。
核心结论
- 肝硬化所致血浆改变可能影响EVAR远期疗效,在权衡腔内与开放修复时应考虑。
- 尽管肝病相关手术风险高,转为开放修复仍可行。
研究设计与样本
- 病例报告:2例肝硬化患者EVAR术后3年随访。
主要发现
- 2例患者均出现显著且进行性AAA瘤囊增大,无内漏影像学征象。
- 第1例为70岁男性,病毒性肝硬化;第2例为71岁男性,酒精性肝病所致肝硬化。
- 两例均成功转为开放AAA修复,术中证实内张力诊断。
临床怎么用
- 对肝硬化患者EVAR术后应警惕无内漏的瘤囊进行性增大。
- 在肝硬化等高危患者选择EVAR或开放修复时,应将内张力风险纳入决策。
局限性
- 仅为2例病例报告,证据级别有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Endotension can present a real challenge for the long-term success of endovascular aortic repair (EVAR). Sometimes, it can be associated with liver dysfunction and consequent plasmatic alterations as in the 2 cases reported here. METHODS: Significant and progressive abdominal aortic aneurysms (AAA) sac enlargement, without radiologic signs of endoleak, was observed in 2 patients during a 3-year follow-up after EVAR. The first was a 70-year-old man affected by viral liver cirrhosis and the second was a 71-year-old man with cirrhosis due to alcoholic liver disease. RESULTS: Both patients underwent successful conversion to open AAA repair; intraoperative findings confirmed the diagnosis of endotension. CONCLUSIONS: Cirrhosis-induced plasmatic alterations may affect long-term efficacy of EVAR and should be considered when weighing endovascular treatment against open AAA repair in these high-risk patients. Surgical conversion is feasible despite the high procedural risk associated with liver disease.
引用
- Cambiaghi T, Baccellieri D, Mascia D, et al. Endotension after Abdominal Aortic Aneurysm Endovascular Repair in Cirrhotic Patients. Ann Vasc Surg. 2017. PMID: 28689941. doi:10.1016/j.avsg.2017.06.148
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。